The longterm outcomes of macular neovascularization treated with intravitreal injections of anti-VGEF drugs

The longterm outcomes of macular neovascularization treated with intravitreal injections of anti-VGEF drugs - AMD treated by anti-VEGF drugs

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000025751

Enrollment

Registered

2017-02-01

Start date

2017-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AMD

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent intravitreal injection to Aflbercept for age-related macular degeneration from February 1, 2016 to August 31, 2017

Exclusion criteria

Exclusion criteria: nothing special

Design outcomes

Primary

Measure	Time frame
Sex, age, visual acuity, visual field, refraction, corneal curvature radius, corneal thickness, ocular axial length, fundus observation,Optical coherence tomography, optical coherence tomography angiography, fundus photograph, fluorescence fundus angiography, slit lamp microscopy, duration of disease, current medical history, past history, family history, medication used, frequency of dosing	—

Countries

Japan

Contacts

Public ContactKeiko Kataoka

Nagoya University Hospital Department of Ophthalmology

kkeiko@med.nagoya-u.ac.jp052-744-2275

Outcome results